APA (7th ed.) Citation

Slobbe, P., & Stehle, G. (2015). A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [11C]erlotinib and [18F]afatinib in lung cancer-bearing mice. EJNMMI Research, 5, . https://doi.org/10.1186/s13550-015-0088-0

Chicago Style (17th ed.) Citation

Slobbe, Paul, and Gerd Stehle. "A Comparative PET Imaging Study with the Reversible and Irreversible EGFR Tyrosine Kinase Inhibitors [11C]erlotinib and [18F]afatinib in Lung Cancer-bearing Mice." EJNMMI Research 5 (2015). https://doi.org/10.1186/s13550-015-0088-0.

MLA (9th ed.) Citation

Slobbe, Paul, and Gerd Stehle. "A Comparative PET Imaging Study with the Reversible and Irreversible EGFR Tyrosine Kinase Inhibitors [11C]erlotinib and [18F]afatinib in Lung Cancer-bearing Mice." EJNMMI Research, vol. 5, 2015, https://doi.org/10.1186/s13550-015-0088-0.